Risk factors of A/H1N1 etiology in pneumonia and its impact on mortality

Respiratory Medicine

Volumn 105, Issue 9, 2011, Pages 1404-1411

  Reyes, S ^a   Montull, B ^a   Martinez R ^a   Cordoba J ^a   Molina, J M ^a   Marti V ^a   Martinez A ^a   Ramirez P ^a,b   Menendez R ^a,b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

C Reactive protein; Coinfection; Influenza a; Mortality; Pneumonia

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE; CREATININE; LACTATE DEHYDROGENASE; NITROGEN; OSELTAMIVIR; UREA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; ESCHERICHIA COLI; FEMALE; HAEMOPHILUS INFLUENZAE; HEART DISEASE; HOSPITAL ADMISSION; HUMAN; INFLUENZA A (H1N1); INTENSIVE CARE UNIT; LACTATE DEHYDROGENASE BLOOD LEVEL; LEGIONELLA PNEUMOPHILA; LEUKOCYTE DIFFERENTIAL COUNT; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIAE; PLEURA EFFUSION; PNEUMONIA; PNEUMONIA SEVERITY INDEX; PRIORITY JOURNAL; PSEUDOMONAS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; C-REACTIVE PROTEIN; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; ODDS RATIO; PANDEMICS; PNEUMONIA, VIRAL; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN;

EID: 79960471407     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.04.011     Document Type: Article

References (45)

1. G. Palacios, M. Hornig, and D. Cisterna Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza PLoS One 4 2009 e8540
2. R.J. Murray, J.O. Robinson, and J.N. White Community-acquired pneumonia due to pandemic A(H1N1)2009 influenzavirus and methicillin resistant Staphylococcus aureus co-infection PLoS One 5 2009 e8705
3. I. Martin-Loeches, A. Sanchez-Corral, and E. Diaz Community-Acquired respiratory co-infection (CARC) in critically ill patients infected with pandemic 2009 influenza A (H1N1) virus infection Chest 139 2011 555 562
4. E. Estenssoro, F.G. Rios, and C. Apezteguia Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation Am J Respir Crit Care Med 182 2010 41 48
5. K. Koon, C.M. Sanders, and J. Green Co-detection of pandemic (H1N1) 2009 virus and other respiratory Pathogens Emerg Infect Dis 16 2010 1976 1978
6. R. Menendez, A. Torres, and J. Aspa Community acquired pneumonia. New guidelines of the Spanish Society of chest diseases and Thoracic Surgery (SEPAR) Arch Bronconeumol 46 2010 543 558
7. I. Alfageme, J. Aspa, and S. Bello Guidelines for the diagnosis and management of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) Arch Bronconeumol 41 2005 272 289 (Pubitemid 41227435)
8. L.A. Mandell, R.G. Wunderink, and A. Anzueto Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 44 Suppl 2 2007 S27 S72
9. R. Perez-Padilla, D. de la Rosa-Zamboni, and S. Ponce de Leon Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico N Engl J Med 361 2009 680 689
10. G. Chowell, S.M. Bertozzi, and M.A. Colchero Severe respiratory disease concurrent with the circulation of H1N1 influenza N Engl J Med 361 2009 674 679
11. S. Jain, L. Kamimoto, and A.M. Bramley Hospitalized patients with 2009 H1N1 influenza in the United States N Engl J Med 361 2009 1935 1944 April-June 2009
12. A. Kumar, R. Zarychanski, and R. Pinto Critically ill patients with 2009 influenza A(H1N1) infection in Canada JAMA 302 2009 1872 1879
13. J.K. Louie, M. Acosta, and K. Winter Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California JAMA 302 2009 1896 1902
14. S. Reyes Calzada, R. Martinez Tomas, and M.J. Cremades Romero Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission Respir Med 101 2007 1909 1915 (Pubitemid 47163539)
15. R. Menendez, A. Torres, and R. Zalacain Guidelines for the treatment of community-acquired pneumonia: predictors of Adherence and outcome Am J Respir Crit Care Med 172 2005 757 762 (Pubitemid 41324232)
16. A. Capelastegui, P.P. Espana, and J.M. Quintana Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study Clin Infect Dis 39 2004 955 963 (Pubitemid 39313450)
17. J.R. Smith, R.E. Ariano, and S. Toovey The use of antiviral agents for the management of severe influenza Crit Care Med 38 2010 e43 51
18. S. Ng, B.J. Cowling, and V.J. Fang Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus Clin Infect Dis 50 2010 707 714
19. P.M. Houck, D.W. Bratzler, and W. Nsa Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia Arch Intern Med 164 2004 637 644 (Pubitemid 38392978)
20. R. Menendez, R. Martinez, and S. Reyes Stability in community-acquired pneumonia: one step forward with markers? Thorax 64 2009 987 992
21. L. Coelho, P. Povoa, and E. Almeida Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course Crit Care 11 2007 R92
22. P. Povoa, L. Coelho, and E. Almeida C-reactive protein as a marker of infection in critically ill patients Clin Microbiol Infect 11 2005 101 108 (Pubitemid 40253814)
23. E. Garcia Vazquez, J.A. Martinez, and J. Mensa C-reactive protein levels in community-acquired pneumonia Eur Respir J 21 2003 702 705 (Pubitemid 36432528)
24. J.D. Chalmers, A. Singanayagam, and A.T. Hill C-reactive protein is an independent predictor of severity in community-acquired pneumonia Am J Med 121 2008 219 225 (Pubitemid 351317927)
25. J.S. Nguyen-Van-Tam, P.J. Openshaw, and A. Hashim Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009) Thorax 65 2009 645 651
26. F.S. Dawood, S. Jain, and L. Finelli Emergence of a novel swine-origin influenza A (H1N1) virus in humans N Engl J Med 360 2009 2605 2615
27. M.J. Fine, T.E. Auble, and D.M. Yealy A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 336 1997 243 250 (Pubitemid 27044625)
28. W.S. Lim, M.M. van der Eerden, and R. Laing Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 58 2003 377 382 (Pubitemid 36560938)
29. CDC protocol of realtime for influenza A(H1N1) Accessed June 23 2009 World Health Organization Geneva http://www.who.int/csr/resources/publications/ swineflu/CDCRealtimeRTPCR-SwineH1Assay-2009-20090430.pdf at
30. D. Hosmer, and S. Lemeshow Applied logistic regression 1989 John Wiley & Sons, Inc ed. New York
31. P.F. Wright, K.B. Kirkland, and J.F. Modlin When to consider the use of antibiotics in the treatment of 2009 H1N1 influenza-associated pneumonia N Engl J Med 361 2009 e112
32. J. Rello, A. Rodriguez, and P. Ibanez Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain Crit Care 13 2009 R148
33. E. Diaz, A. Rodriguez, and I. Martin-Loeches Impact of obesity in patients infected with new influenza A(H1N1) Chest 139 2011 382 386
34. P.R. Ingram, T. Inglis, and D. Moxon Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection Intensive Care Med 36 2009 528 532
35. J. Rello, and A. Pop-Vicas Clinical review: primary influenza viral pneumonia Crit Care 13 2009 235
36. S. Mulrennan, S.S. Tempone, and I.T. Ling Pandemic influenza (H1N1) 2009 pneumonia: CURB-65 score for predicting severity and nasopharyngeal sampling for diagnosis are unreliable PLoS One 5 2010 e12849
37. A.H. Bruns, J.J. Oosterheert, and E. Hak Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia Eur Respir J 32 2008 726 732
38. R. Menendez, R. Martinez, and S. Reyes Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia Thorax 64 2009 587 591
39. X. Xi, Y. Xu, and L. Jiang Hospitalized adult patients with 2009 influenza A(H1N1) in Beijing, China: risk factors for hospital mortality BMC Infect Dis 10 2010 256
40. G. Dominguez-Cherit, S.E. Lapinsky, and A.E. Macias Critically Ill patients with 2009 influenza A(H1N1) in Mexico JAMA 302 2009 1880 1887
41. R. Riquelme, A. Torres, and M.L. Rioseco Influenza pneumonia: a comparison between seasonal influenza virus and H1N1 pandemic Eur Respir J 2011 [Epub Ahead of print]
42. M.A. Mamas, D. Fraser, and L. Neyses Cardiovascular manifestations associated with influenza virus infection Int J Cardiol 130 2008 304 309
43. C. Warren-Gash, L. Smeeth, and A.C. Hayward Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review Lancet Infect Dis 9 2009 601 610
44. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States MMWR Morb Mortal Wkly Rep 58 2009 1071 1074 May-August 2009
45. P.D. Tamma, A.E. Turnbull, and A.M. Milstone Clinical outcomes of seasonal influenza and pandemic influenza A (H1N1) in pediatric inpatients BMC Pediatr 10 2010 72